ID

117

Descrizione

ODM derived from http://clinicaltrials.gov/show/NCT00157157

collegamento

http://clinicaltrials.gov/show/NCT00157157

Keywords

  1. 28/11/11 28/11/11 -
  2. 13/04/14 13/04/14 - Julian Varghese
  3. 13/04/21 13/04/21 - Dr. rer. medic Philipp Neuhaus
  4. 20/09/21 20/09/21 -
Caricato su

28 novembre 2011

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0 Legacy

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility NCT00157157 Hemophilia

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Descrizione

Inclusion Criteria

The subject has severe or moderately severe hemophilia A as defined by a baseline factor VIII level <= 2% of normal, as documented at screening
Descrizione

Hemophilia A

Tipo di dati

boolean

The subject is < 6 years of age
Descrizione

Age

Tipo di dati

boolean

The subject's legally authorized representative has provided written informed consent
Descrizione

Informed consent

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

The subject has a history of exposure to factor VIII other than rAHF PFM or more than 3 infusions of commercially available rAHF PFM (i.e., ADVATE) within 28 days prior to screening, as determined by the subject's medical history. Any infusion of factor VIII replacement products prior to the 28-day period excludes the subject from participation
Descrizione

other factor VIII

Tipo di dati

boolean

The subject has received more than 3 infusions of rAHF PFM (commercially available and/or study product) between screening and prior to the initial recovery infusion
Descrizione

previous rAHF PFM

Tipo di dati

boolean

The subject has a detectable inhibitor to factor VIII, as measured in the screening sample by the Nijmegen assay in the central laboratory
Descrizione

inhibitor to factor VIII

Tipo di dati

boolean

The subject has a history of inhibitor to factor VIII at any time prior to screening
Descrizione

history of inhibitor to factor VIII

Tipo di dati

boolean

The subject has a known hypersensitivity to rAHF PFM
Descrizione

Hypersensitivity to rAHF PFM

Tipo di dati

boolean

The subject has any 1 of the following laboratory abnormalities at the time of screening: 1) Platelet count < 100,000/mm^3 2) Hemoglobin concentration < 10 g/dL (100 g/L) 3) Serum creatinine > 1.5 times the upper limit of normal (ULN) for age 4) Total bilirubin > 2 times the ULN for age
Descrizione

Lab abnormalities

Tipo di dati

boolean

The subject has an inherited or acquired hemostatic defect other than hemophilia A (e.g., qualitative platelet defect or von Willebrand's disease)
Descrizione

other hemostatic defect than hemophilia A

Tipo di dati

boolean

The subject is known to be seropositive for human immunodeficiency virus (HIV), hepatitis C virus (HCV), or hepatitis B virus (HBV), as determined by the subject's medical history
Descrizione

HIV, HCV, HBV

Tipo di dati

boolean

At the time of enrollment, the subject has a clinically significant chronic disease other than hemophilia A
Descrizione

significant chronic disease

Tipo di dati

boolean

The subject is currently participating in another investigational drug study, or has participated in any clinical study involving an investigational drug within 120 days of the screening visit
Descrizione

other trial

Tipo di dati

boolean

The subject (or the subject's legally authorized representative) is identified by the investigator as being unable or unwilling to cooperate with study procedures
Descrizione

non-compliance to study procedures

Tipo di dati

boolean

The subject has received any blood product, including packed red blood cells (RBC), platelets, plasma, or cryoprecipitate
Descrizione

received blood product

Tipo di dati

boolean

Medical concepts
Descrizione

Medical concepts

Diagnosis
Descrizione

Diagnosis

Tipo di dati

string

Alias
UMLS CUI
C0011900
SNOMED CT 2010_0731
439401001
LOINC Version 232
MTHU008876
Hemophilia A
Descrizione

Factor VIII deficiency

Tipo di dati

string

Alias
UMLS CUI
C0019069
SNOMED CT 2010_0731
234440005
MedDRA 13.1
10016080
ICD-10-CM Version 2010
D66
ICD-9-CM Version 2011
286.0
Factor VIII Measurement
Descrizione

Coagulation factor VIII activity actual/Normal

Tipo di dati

string

Alias
UMLS CUI
C2825857
LOINC Version 232
3209-4
Age
Descrizione

Age

Tipo di dati

string

Alias
UMLS CUI
C0001779
SNOMED CT 2010_0731
102518004
Informed Consent
Descrizione

Informed Consent

Tipo di dati

string

Alias
UMLS CUI
C0021430
Medication
Descrizione

Pharmaceutical Preparations

Tipo di dati

string

Alias
UMLS CUI
C0013227
Factor VIII
Descrizione

Factor VIII

Tipo di dati

string

Alias
UMLS CUI
C0015506
SNOMED CT 2010_0731
278910002
LOINC Version 232
MTHU009422
Factor VIII inhibitor screening test
Descrizione

Factor VIII inhibitor screening test

Tipo di dati

string

Alias
UMLS CUI
C1446152
SNOMED CT 2010_0731
413021006
Hypersensitivity
Descrizione

Allergy

Tipo di dati

string

Alias
UMLS CUI
C0020517
SNOMED CT 2010_0731
257550005
ICD-10-CM Version 2010
T78.40
Platelet count - finding
Descrizione

Platelet count

Tipo di dati

string

Alias
UMLS CUI
C1287267
SNOMED CT 2010_0731
365632008
LOINC Version 232
777-3
Hemoglobin
Descrizione

Hemoglobin

Tipo di dati

string

Alias
UMLS CUI
C0019046
SNOMED CT 2010_0731
38082009
MedDRA 13.1
10019481
LOINC Version 232
LP14449-0
Creatinine
Descrizione

Creatinine

Tipo di dati

string

Alias
UMLS CUI
C0010294
SNOMED CT 2010_0731
15373003
MedDRA 13.1
10011358
LOINC Version 232
38483-4
Bilirubin
Descrizione

Bilirubin

Tipo di dati

string

Alias
UMLS CUI
C0011221
SNOMED CT 2010_0731
79706000
LOINC Version 232
1975-2
Coagulation Factor Deficiency
Descrizione

Coagulation Factor Deficiency

Tipo di dati

string

Alias
UMLS CUI
C0849773
SNOMED CT 2010_0731
86075001
MedDRA 13.1
10067787
ICD-9-CM Version 2011
286
HIV negative
Descrizione

HIV negative

Tipo di dati

string

Alias
UMLS CUI
C0481430
SNOMED CT 2010_0731
143223008
MedDRA 13.1
10020179
Hepatitis
Descrizione

Hepatitis

Tipo di dati

string

Alias
UMLS CUI
C0019158
SNOMED CT 2010_0731
29001004
MedDRA 13.1
10019717
Enrollment
Descrizione

Enrollment

Tipo di dati

string

Alias
UMLS CUI
C1516879
Compliance
Descrizione

Compliance

Tipo di dati

string

Alias
UMLS CUI
C1321605
SNOMED CT 2010_0731
405078008
Blood product
Descrizione

Blood product

Tipo di dati

string

Alias
UMLS CUI
C0456388
SNOMED CT 2010_0731
410652009
HL7 V3 02-34
BLDPRD

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Inclusion Criteria
Hemophilia A
Item
The subject has severe or moderately severe hemophilia A as defined by a baseline factor VIII level <= 2% of normal, as documented at screening
boolean
Age
Item
The subject is < 6 years of age
boolean
Informed consent
Item
The subject's legally authorized representative has provided written informed consent
boolean
Item Group
Exclusion Criteria
other factor VIII
Item
The subject has a history of exposure to factor VIII other than rAHF PFM or more than 3 infusions of commercially available rAHF PFM (i.e., ADVATE) within 28 days prior to screening, as determined by the subject's medical history. Any infusion of factor VIII replacement products prior to the 28-day period excludes the subject from participation
boolean
previous rAHF PFM
Item
The subject has received more than 3 infusions of rAHF PFM (commercially available and/or study product) between screening and prior to the initial recovery infusion
boolean
inhibitor to factor VIII
Item
The subject has a detectable inhibitor to factor VIII, as measured in the screening sample by the Nijmegen assay in the central laboratory
boolean
history of inhibitor to factor VIII
Item
The subject has a history of inhibitor to factor VIII at any time prior to screening
boolean
Hypersensitivity to rAHF PFM
Item
The subject has a known hypersensitivity to rAHF PFM
boolean
Lab abnormalities
Item
The subject has any 1 of the following laboratory abnormalities at the time of screening: 1) Platelet count < 100,000/mm^3 2) Hemoglobin concentration < 10 g/dL (100 g/L) 3) Serum creatinine > 1.5 times the upper limit of normal (ULN) for age 4) Total bilirubin > 2 times the ULN for age
boolean
other hemostatic defect than hemophilia A
Item
The subject has an inherited or acquired hemostatic defect other than hemophilia A (e.g., qualitative platelet defect or von Willebrand's disease)
boolean
HIV, HCV, HBV
Item
The subject is known to be seropositive for human immunodeficiency virus (HIV), hepatitis C virus (HCV), or hepatitis B virus (HBV), as determined by the subject's medical history
boolean
significant chronic disease
Item
At the time of enrollment, the subject has a clinically significant chronic disease other than hemophilia A
boolean
other trial
Item
The subject is currently participating in another investigational drug study, or has participated in any clinical study involving an investigational drug within 120 days of the screening visit
boolean
non-compliance to study procedures
Item
The subject (or the subject's legally authorized representative) is identified by the investigator as being unable or unwilling to cooperate with study procedures
boolean
received blood product
Item
The subject has received any blood product, including packed red blood cells (RBC), platelets, plasma, or cryoprecipitate
boolean
Item Group
Medical concepts
Diagnosis
Item
Diagnosis
string
C0011900 (UMLS CUI)
439401001 (SNOMED CT 2010_0731)
MTHU008876 (LOINC Version 232)
Factor VIII deficiency
Item
Hemophilia A
string
C0019069 (UMLS CUI)
234440005 (SNOMED CT 2010_0731)
10016080 (MedDRA 13.1)
D66 (ICD-10-CM Version 2010)
286.0 (ICD-9-CM Version 2011)
Coagulation factor VIII activity actual/Normal
Item
Factor VIII Measurement
string
C2825857 (UMLS CUI)
3209-4 (LOINC Version 232)
Age
Item
Age
string
C0001779 (UMLS CUI)
102518004 (SNOMED CT 2010_0731)
Informed Consent
Item
Informed Consent
string
C0021430 (UMLS CUI)
Pharmaceutical Preparations
Item
Medication
string
C0013227 (UMLS CUI)
Factor VIII
Item
Factor VIII
string
C0015506 (UMLS CUI)
278910002 (SNOMED CT 2010_0731)
MTHU009422 (LOINC Version 232)
Factor VIII inhibitor screening test
Item
Factor VIII inhibitor screening test
string
C1446152 (UMLS CUI)
413021006 (SNOMED CT 2010_0731)
Allergy
Item
Hypersensitivity
string
C0020517 (UMLS CUI)
257550005 (SNOMED CT 2010_0731)
T78.40 (ICD-10-CM Version 2010)
Platelet count
Item
Platelet count - finding
string
C1287267 (UMLS CUI)
365632008 (SNOMED CT 2010_0731)
777-3 (LOINC Version 232)
Hemoglobin
Item
Hemoglobin
string
C0019046 (UMLS CUI)
38082009 (SNOMED CT 2010_0731)
10019481 (MedDRA 13.1)
LP14449-0 (LOINC Version 232)
Creatinine
Item
Creatinine
string
C0010294 (UMLS CUI)
15373003 (SNOMED CT 2010_0731)
10011358 (MedDRA 13.1)
38483-4 (LOINC Version 232)
Bilirubin
Item
Bilirubin
string
C0011221 (UMLS CUI)
79706000 (SNOMED CT 2010_0731)
1975-2 (LOINC Version 232)
Coagulation Factor Deficiency
Item
Coagulation Factor Deficiency
string
C0849773 (UMLS CUI)
86075001 (SNOMED CT 2010_0731)
10067787 (MedDRA 13.1)
286 (ICD-9-CM Version 2011)
HIV negative
Item
HIV negative
string
C0481430 (UMLS CUI)
143223008 (SNOMED CT 2010_0731)
10020179 (MedDRA 13.1)
Hepatitis
Item
Hepatitis
string
C0019158 (UMLS CUI)
29001004 (SNOMED CT 2010_0731)
10019717 (MedDRA 13.1)
Enrollment
Item
Enrollment
string
C1516879 (UMLS CUI)
Compliance
Item
Compliance
string
C1321605 (UMLS CUI)
405078008 (SNOMED CT 2010_0731)
Blood product
Item
Blood product
string
C0456388 (UMLS CUI)
410652009 (SNOMED CT 2010_0731)
BLDPRD (HL7 V3 02-34)

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial